Skip to content
DeepViews

LanzaTech Global, Inc. Common Stock (LNZA) β€” Analysis Summary

LanzaTech Global, Inc. Common Stock (LNZA) has a market cap of $80.24M with year-over-year revenue growth of +12.6%. Net margin stands at -87.7%. The stock trades at a P/E ratio of 0.5.

Key Takeaways

  • Revenue changed +12.6% year-over-year
  • Net margin of -87.7%
  • P/E ratio of 0.5

Compared to other companies in the INDUSTRIAL ORGANIC CHEMICALS sector, LNZA posted revenue growth of +12.6% and trades at a P/E of 0.5.

[XNAS]

LanzaTech Global, Inc. Common Stock (LNZA)

$6.10

PREVIOUS CLOSE 2026-10-12 Β· MARKET DATA POLYGON Β· FINANCIALS SEC EDGAR

Market Cap
$80.24M
Enterprise Value
$35.26M
P/E Ratio
0.5
Div Yield
0.00%
EV/EBITDA
-1.1
Company Profile
About
About LanzaTech Global, Inc. Common Stock

LanzaTech Global Inc is a provider of carbon management and conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical industrial inputs. Its mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging scalable biotechnology solutions to maximize the value of domestic resources. The company operates in North America, Europe, the Middle East, Africa (EMEA), Asia, and Australia, with the majority of its revenue generated from North America.

Sector

INDUSTRIAL ORGANIC CHEMICALS

Employees

192

Headquarters

SKOKIE, IL

Exchange

XNAS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
27
No Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$260.64M
Total Debt$0.00M
Debt-to-Equity0.00
Cash & Equivalents$44.98M

Cash Flow

Operating Cash Flow$-32.70M
Free Cash Flow$-33.80M
FCF Margin-57.97%
P/FCF Ratio-2.37
Source: Polygon.io Β· SEC EDGAR
Dividends
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.

LanzaTech Global, Inc. (LNZA) β€” Fair Value, DCF, Moat Analysis β€” P/E 0.5x, $80M | DeepViews